Abstract:ABSTRACT Filoviruses produce viral particles with characteristic filamentous morphology. The major viral matrix protein, VP40, is trafficked to the plasma membrane and promotes viral particle formation and subsequent viral egress. In the present study, we assessed the role of the small GTPase Rab11-mediated endocytic pathway in Marburg virus (MARV) particle formation and budding. Although Rab11 was predominantly localized in the perinuclear region, it exhibited a more diffuse distribution in the cytoplasm of cells transiently expressing MARV VP40. Rab11 was incorporated into MARV-like particles. Expression of the dominant-negative form of Rab11 and knockdown of Rab11 decreased the amount of VP40 fractions in the cell periphery. Moreover, downregulation of Rab11 moderately reduced the release of MARV-like particles and authentic MARV. We further demonstrated that VP40 induces the distribution of the microtubule network toward the cell periphery, which was partly associated with Rab11. Depolymerization of microtubules reduced the accumulation of VP40 in the cell periphery along with viral particle formation. VP40 physically interacted with α-tubulin, a major component of microtubules, but not with Rab11. Taken together, these results suggested that VP40 partly interacts with microtubules and facilitates their distribution toward the cell periphery, leading to the trafficking of transiently tethering Rab11-positive vesicles toward the cell surface. As we previously demonstrated the role of Rab11 in the formation of Ebola virus particles, the results here suggest that filoviruses in general exploit the vesicle-trafficking machinery for proper virus-particle formation and subsequent egress. These pathways may be a potential target for the development of pan-filovirus therapeutics. IMPORTANCE Filoviruses, including Marburg and Ebola viruses, produce distinct filamentous viral particles. Although it is well known that the major viral matrix protein of these viruses, VP40, is trafficked to the cell surface and promotes viral particle production, details regarding the associated molecular mechanisms remain unclear. To address this knowledge gap, we investigated the role of the small GTPase Rab11-mediated endocytic pathway in this process. Our findings revealed that Marburg virus exploits the Rab11-mediated vesicle-trafficking pathway for the release of virus-like particles and authentic virions in a microtubule network-dependent manner. Previous findings demonstrated that Rab11 is also involved in Ebola virus-particle production. Taken together, these data suggest that filoviruses, in general, may hijack the microtubule-dependent vesicle-trafficking machinery for productive replication. Therefore, this pathway presents as a potential target for the development of pan-filovirus therapeutics.

Pseudotyped Viruses for Marburgvirus and Ebolavirus

A Novel and Secure Pseudovirus Reporter System Based Assay for Neutralizing and Enhancing Antibody Assay Against Marburg Virus

Structural and Molecular Basis for Ebola Virus Neutralization by Protective Human Antibodies

Rational design of self-amplifying virus-like vesicles with Ebola virus glycoprotein as vaccines

Pseudotyped Viruses for Mammarenavirus

Development of a Měnglà virus minigenome and comparison of its polymerase complexes with those of other filoviruses

The Lifecycle of the Ebola Virus in Host Cells.

Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo

Mapping knowledge landscapes and emerging trends of Marburg virus: A text-mining study

Marburg virus pathogenesis – differences and similarities in humans and animal models

Development of high-content imaging assays for lethal viral pathogens

Marburg Virus Disease – A Mini-Review

Non-Ebola Filoviruses: Potential Threats to Global Health Security

Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies

Pseudotyped Viruses for Coronaviruses

Marburg virus exploits the Rab11-mediated endocytic pathway in viral-particle production

Pathogenicity and virulence of Marburg virus

Ebola virus outbreak, updates on current therapeutic strategies

Construction and applications of SARS-CoV-2 pseudoviruses: a mini review

Marburg virus VP35 can both fully coat the backbone and cap the ends of dsRNA for interferon antagonism

A novel MARV glycoprotein-specific antibody with potentials of broad-spectrum neutralization to filovirus